#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13378	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2645	611.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	2002	2002	T	862	T,C,G,A	859,1,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13378	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2645	611.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1736	1736	C	820	C	820	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13378	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2645	611.2	0	HET	.	.	.	A263G,T	.	263	263	A	815	815	A	796	A,G,T	608,187,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22364	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4111	677.7	0	.	n	.	0	C265T	SNP	265	265	C	816	816	T	824	T,A,C,G	817,4,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22364	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4111	677.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1888	1888	A	873	A,C	871,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22364	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4111	677.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2522	2522	C	821	C	821	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22364	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4111	677.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2596	2596	A	752	A,G,C	750,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22364	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4111	677.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3148	3148	C	783	C	783	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	44540	blaTEM	861	861	100.0	blaTEM.l15.c17.ctg.1	2032	2727.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1778	folP	855	855	100.0	folP.l15.c17.ctg.1	2144	103.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1383	1385	AGC	183;185;188	A,G,C;G,A;C,T	181,1,1;184,1;186,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4182	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	4105	127.1	1	SNP	p	S91F	0	.	.	271	273	TCC	980	982	TCC	161;160;160	T;C;C	161;160;160	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4182	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	4105	127.1	1	SNP	p	D95G	0	.	.	283	285	GAC	992	994	GAC	173;175;174	G;A;C	173;175;174	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4182	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	4105	127.1	1	SNP	p	D95N	0	.	.	283	285	GAC	992	994	GAC	173;175;174	G;A;C	173;175;174	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1542	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1857	103.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	789	791	ACC	127;127;129	A,T;C;C	126,1;127;129	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1542	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1857	103.2	0	.	p	.	0	L47P	NONSYN	139	141	CTC	813	815	CCC	137;140;140	C;C;C	137;140;140	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1542	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1857	103.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	987	989	CAC	204;203;206	C,T,G;A;C	201,1,1;203;206	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1542	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1857	103.2	1	SNP	p	G45D	0	.	.	133	135	GGC	807	809	GGC	135;134;134	G;G;C	135;134;134	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	952	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1477	80.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4690	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3479	167.8	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1800	1802	ATC	214;212;210	A;T;C,T	214;212;209,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4690	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3479	167.8	1	SNP	p	D86N	0	.	.	256	258	GAC	906	908	GAC	193;198;198	G;A,G;C	193;197,1;198	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4690	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3479	167.8	1	SNP	p	S87I	0	.	.	259	261	AGT	909	911	AGT	198;198;196	A,C;G;T	197,1;198;196	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4690	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3479	167.8	1	SNP	p	S87W	0	.	.	259	261	AGT	909	911	AGT	198;198;196	A,C;G;T	197,1;198;196	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4690	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3479	167.8	1	SNP	p	S87R	0	.	.	259	261	AGT	909	911	AGT	198;198;196	A,C;G;T	197,1;198;196	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4690	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3479	167.8	1	SNP	p	S88P	0	.	.	262	264	TCC	912	914	TCC	197;197;197	T;C,A;C,T	197;196,1;196,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3590	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3186	140.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1800	1802	GGC	189;187;187	G,C;G;C	188,1;187;187	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1490	1492	GCA	187;186;186	G,T;C,A;A	186,1;185,1;186	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1493	1495	ATC	182;181;181	A;T;C	182;181;181	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1505	1507	GTG	189;191;190	G;T;G	189;191;190	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1505	1507	GTG	189;191;190	G;T;G	189;191;190	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2009	2011	ACC	180;180;179	A,C;C;C	179,1;180;178	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2063	2065	GCG	174;177;180	G;C;G	174;177;180	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2063	2065	GCG	174;177;180	G;C;G	174;177;180	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2186	2188	GGC	192;192;193	G;G;C	192;192;193	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2195	2197	GGC	190;190;189	G,A;G,A;C	189,1;189,1;189	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3328	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2954	140.5	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2213	2215	TCG	193;194;191	T,G;C;G,A	192,1;194;190,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4968	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3410	180.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1768	1770	CCG	194;197;198	C;C,A;G	193;195,1;197	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2128	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2292	115.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	795	795	C	138	C	138	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	100	95.0	porB1a.l15.c4.ctg.3	182	44.0	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	56;55;50	A;C,T;G	56;54,1;50	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	100	95.0	porB1a.l15.c4.ctg.3	182	44.0	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	12;10;10	C;A;A	12;10;10	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	2662	porB1b	1041	1041	100.0	porB1b.l15.c30.ctg.1	2154	153.8	1	SNP	p	G120K	1	.	.	358	360	AAG	1050	1052	AAG	196;197;199	A;A;G	196;197;199	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	2662	porB1b	1041	1041	100.0	porB1b.l15.c30.ctg.1	2154	153.8	1	SNP	p	A121D	1	.	.	361	363	GAC	1053	1055	GAC	198;201;203	G;A;C	198;201;203	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	2662	porB1b	1041	1041	100.0	porB1b.l15.c30.ctg.1	2154	153.8	1	SNP	p	D121N	0	.	.	361	363	GAC	1053	1055	GAC	198;201;203	G;A;C	198;201;203	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9182	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5477	208.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2269	2271	CAT	225;225;224	C,G,A;A;T	223,1,1;225;224	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1316	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1600	102.7	1	SNP	p	V57M	1	.	.	169	171	ATG	802	804	ATG	231;229;229	A,G;T;G	230,1;229;229	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
